Skip to main content

Safety and Efficacy of AK0529 in Respiratory Syncytial Virus-Infected Infant Patients: a Phase 2 Proof-of-Concept Trial.

Authorea Preprints

Huang, L.M., Schibler, A., Huang, Y.C., Tai, A., Chi, H., Chieng, C.H., Wang, J.L., Goldbart, A., Tang, S.P., Huang, Y.C. and George, S., 2022. Safety and Efficacy of AK0529 in Respiratory Syncytial Virus-Infected Infant Patients: a Phase 2 Proof-of-Concept Trial. Authorea Preprints. 


Last updated 04 Dec 2023